Tag: MDGS

RTTR Pops, Options Recaps & More

Ritter Pharmaceuticals Inc. RTTR

We were looking for a big start to the week, which we did get with our options ideas on Monday, but we also included RTTR in that report, and yesterday the stock really went for a ride.

From a low of .332 Monday morning, to yesterday’s new high of .74 it marks a two-day upswing and total possible gains of 123%

Options Updates

We also formulated several options ideas in yesterday morning’s premarket report, and were flushed with solid opportunities to profit in 3 out of our 4 target ranges. Here are the moves made by those contracts on the day:

CHGG 05/15 $45-55 Calls
$45: 8.00-16.19 (+102%)
$50: 4.00-12.00 (+200%)
$55: 1.36-7.89 (+480%)
_____

PTON Weekly $34-35 Calls*
$34: 2.96-4.00 (+35%)
$35: 2.41-3.50 (+45%)

*Based on premarket activity, we expect to see the gains here increased today, so keep an eye peeled.
_____

SPY 05/06 $285-288 Calls
$285: 2.93-4.83 (+65%)
$286: 2.36-4.04 (+71%)
$287: 1.83-3.30 (+80%)
$288: 1.37-2.64 (+93%)

Fresh Options Ideas:
CVS Weekly $62-63 Calls
EA Weekly $120-115 Puts
INMD 05/15 $25-30 Calls
CLVS Weekly $8-8.50 Calls

Extended Watchlist:
MDGS, ALA, POAI, VNTR, CARS, MELI,

Blue Horseshoe Stocks: AYTU Update & More

Aytu BioScience, Inc. AYTU Yesterday morning, we were just discussing AYTU and the modest progress the stock had made since we flagged it as a bottom play in Wednesday’s premarket report. Not only had it displayed a cherry bottom setup, but we noted a string of insider buysat the time as well.Following that report, we would witness a low of .4118, and over the course of the ensuing four trading days, the stock has made a noteworthy move and continues to exhibit signs that more gains could be in store.

Yesterday it reached .61, which represents a run of 48% in under a week. It did so on record volume, so we’re definitely eager to see where the momentum could carry this play that was already on its way back up.

InspireMD, Inc. NSPR

NSPR has been in real trouble in 2018, losing ground at seemingly every turn and unable to get out of its own way. However, through a combination of a South American breakthrough announcement for two of the companies drugs, and being just plain oversold, we’re seeing a marginal premarket gap-up and will want to observe for a more sustained rebound.

The news was pertaining to NSPR receiving regulatory approval from the goverment of Peru for its CGuard™ Embolic Prevention System (EPS) and MGuard Prime™ products. Peru has a population of more than 30 million people. (>>View PR)

Extended Watchlist:
ARWR, GLOW, MDGS, MBRX, SEE, WBAI, LIQT, PIXY,

Blue Horseshoe Stocks: RIOT, EGBN & More

Riot Blockchain, Inc. RIOT

We began tracking RIOT on November 2nd at a low of 6.33, mentioning it three times over the course of the next month. The stock saw a massive run ending last Monday hitting a high of 21.76, for a hefty move of 244%

It spent the rest of the week beginning to rebound off of the pullback to the $12-range which followed that huge spike, and is presently trading back in the $16-range. We’re going to want to continue to keep an eye on this blockchain related play, as almost anything even remotely tied to the white-hot sector has a chance to see further surges at any time if the price of BTC sees more new highs. As of this morning, one Bitcoin is worth just over $11,000USD.

Verizon, Inc. VZ

It has been a very solid run for VZ since we signaled a range of contracts to observe on the morning of November 17th, the VZ 01/19 $45-48 Calls.  We saw the stock trading at 44.62, and that was followed by sessions after session of new highs leading all the way through Friday, when it reached  51.55.

We wanted to provide yet another update on the total ranges of gains that were available in our options idea in the two weeks we’ve been tracking it now:

VZ 01/19 $45-48 Calls
$45 Calls – Range: 1.08 -6.40 – Max Gain: 493%
$46 Calls – Range: .59-5.48 – Max Gain: 829%
$47 Calls – Range: .39-4.56 – Max Gain: 1069%
$48 Calls – Range: .23-3.34 – Max Gain: 1352%


Eagle Bancorp, Inc. EGBN

We noticed an interesting set of events playing out with EGBN- the stock absolutely fell off a cliff last week, tumbling from nearly $70 on Wednesday, to the low $46-range on Friday. Apparently it was the result of a hyped up short seller report by Aurelius Value, an anonymous online firm that supports short-sellers. The company published a statement of its own calling the report “a deceptive and materially misleading piece“.

We tend to give credence to the actual company’s public statement rather than a group of shorts hiding behind a curtain somewhere. That’s why we’re going to place the EGBN 12/15 $50-60 Calls on watch in the days and weeks ahead, for what should be a forthcoming recovery in EGBN.

Extended Watchlist:
APRN, ASNA, CHFS, DPW, MDGS, PXS, UUUU, RSLS